These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6365748)

  • 1. Role of hyaluronidase in in vitro phagocytosis of encapsulated yeasts of Cryptococcus neoformans.
    Mathai A; Radhakrishnan VV
    Indian J Exp Biol; 1983 May; 21(5):285-8. PubMed ID: 6365748
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential binding of acapsulate and encapsulated strains of Cryptococcus neoformans to human neutrophils.
    Richardson MD; White LJ; McKay IC; Shankland GS
    J Med Vet Mycol; 1993; 31(3):189-99. PubMed ID: 8360810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of different hyaluronidases on the in vitro phagocytosis of Staphylococcus aureus by polymoprphonuclear leucocytes.
    el-Sokkary A; Ayad EM; Hassouna NA
    J Egypt Med Assoc; 1975; 58(9-10):513-25. PubMed ID: 1236522
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro.
    Diamond RD; Root RK; Bennett JE
    J Infect Dis; 1972 Apr; 125(4):367-76. PubMed ID: 4553080
    [No Abstract]   [Full Text] [Related]  

  • 5. The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages.
    Kozel TR; Gotschlich EC
    J Immunol; 1982 Oct; 129(4):1675-80. PubMed ID: 7050244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro studies on the effect of different hyaluronidases on the phagocytosis of Staphylococcus aureus.
    el-Sokkary A; Ayad E
    J Egypt Med Assoc; 1977; 60(3-4):179-85. PubMed ID: 608892
    [No Abstract]   [Full Text] [Related]  

  • 7. Oxidative killing of Cryptococcus neoformans by human neutrophils. Evidence that fungal mannitol protects by scavenging reactive oxygen intermediates.
    Chaturvedi V; Wong B; Newman SL
    J Immunol; 1996 May; 156(10):3836-40. PubMed ID: 8621921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in outcome of the interaction between Cryptococcus neoformans glucuronoxylomannan and human monocytes and neutrophils.
    Monari C; Retini C; Casadevall A; Netski D; Bistoni F; Kozel TR; Vecchiarelli A
    Eur J Immunol; 2003 Apr; 33(4):1041-51. PubMed ID: 12672070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of interleukin-6 mRNA in rat alveolar macrophages by in vitro exposure to both Cryptococcus neoformans and anti-C. neoformans antiserum.
    Li RK; Mitchell TG
    J Med Vet Mycol; 1997; 35(5):327-34. PubMed ID: 9402525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique hybrids between the fungal pathogens Cryptococcus neoformans and Cryptococcus gattii.
    Bovers M; Hagen F; Kuramae EE; Diaz MR; Spanjaard L; Dromer F; Hoogveld HL; Boekhout T
    FEMS Yeast Res; 2006 Jun; 6(4):599-607. PubMed ID: 16696655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The phenoloxidase test and its application to identify Cryptococcus neoformans with various biological characteristics].
    Li A; Wu S
    Wei Sheng Wu Xue Bao; 1995 Apr; 35(2):97-102. PubMed ID: 7483579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monoclonal antibodies recognizing the capsular polysaccharide of Cryptococcus neoformans].
    Rodríguez Sánchez H; Pupo Antúnez M; Ilnait MT; Otero A; Martínez Machín G
    Rev Cubana Med Trop; 2005; 57(2):162-4. PubMed ID: 17966590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opsonization and phagocytosis of Cryptococcus neoformans.
    Kozel TR
    Arch Med Res; 1993; 24(3):211-8. PubMed ID: 8298269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between Cryptococcus neoformans and alveolar macrophages.
    Gross NT; Nessa K; Camner P; Chinchilla M; Jarstrand C
    J Med Vet Mycol; 1997; 35(4):263-9. PubMed ID: 9292423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunology of infection caused by Cryptococcus neoformans.
    Wormley FL; Perfect JR
    Methods Mol Med; 2005; 118():193-8. PubMed ID: 15888944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactions.
    Zaragoza O; Taborda CP; Casadevall A
    Eur J Immunol; 2003 Jul; 33(7):1957-67. PubMed ID: 12884862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparisons between in vitro glial cell adherence and internalization of non-encapsulated and encapsulated strains of Cryptococcus neoformans.
    Merkel GJ; Scofield BA
    J Med Vet Mycol; 1994; 32(5):361-72. PubMed ID: 7531242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phagocytosis and proliferation of Cryptococcus neoformans in stimulated macrophages of guinea pigs in vitro (author's transl)].
    Splino M; Kyntera F
    Bratisl Lek Listy; 1978 Nov; 70(5):575-85. PubMed ID: 363245
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolation of Cryptococcus neoformans from pigeon manure on two media inducing pigment formation.
    Schønheyder H; Stenderup A
    Sabouraudia; 1982 Sep; 20(3):193-7. PubMed ID: 6753189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyaluronidase and the bacterial phagocytosis of leucocytes].
    LUDANY G; ORBAN T; VAJDA J
    Arch Int Pharmacodyn Ther; 1952 Jan; 88(4):496-502. PubMed ID: 14934382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.